Skip to main content
OpenTrials

Clinical trial condition

Alzheimer's Disease

Explore clinical trials studying Alzheimer's Disease. Study availability and eligibility vary by location and protocol.

802 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Alzheimer's Disease trial results

Completed

Clinical Pathway for Alzheimer's Disease in China (CPAD)

NCT01779310

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Anzhen Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Shijitan Hospital Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
View all 28 locations
View Trial Details
Completed

A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease

NCT00459550

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • GSK Investigational Site Herston, Queensland, Australia
  • GSK Investigational Site Heidelberg Heights, Victoria, Australia
  • GSK Investigational Site Fremantle, Western Australia, Australia
  • GSK Investigational Site Lørenskog, Norway
View Trial Details
Completed

A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

NCT01397578

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • Banner Alzheimer's Institute Phoenix, Arizona, United States
  • Banner Sun Health Research Insitute Sun City, Arizona, United States
  • NNS Clinical Research LLC Tucson, Arizona, United States
  • Margolin Brain Institute Fresno, California, United States
View all 29 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

NCT01343966

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • Hope Research Institute Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Pharmacology Research Inst Encino, California, United States
  • Margolin Brain Institute Fresno, California, United States
View all 92 locations
View Trial Details
Completed

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

NCT00675090

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • GSK Investigational Site Randwick, New South Wales, Australia
  • GSK Investigational Site Heidelberg Heights, Victoria, Australia
  • GSK Investigational Site Prague, Czechia
  • GSK Investigational Site Seoul, South Korea
View Trial Details

Related conditions